Factors affecting keratoconus progression and corneal collagen cross-linking

Clin Exp Ophthalmol. 2020 May;48(4):531-532. doi: 10.1111/ceo.13723. Epub 2020 Feb 17.

Authors

Elsie Chan^{1

2

3}, Harry Yip¹, Sara Vogrin^{3

4}, Srujana Sahebjada^{2

3}

Affiliations

¹ Cornea Unit, Royal Victorian Eye and Ear Hospital, Melbourne, Victoria, Australia.
² Centre for Eye Research Australia, University of Melbourne, Melbourne, Victoria, Australia.
³ Department of Surgery, University of Melbourne, Melbourne, Victoria, Australia.
⁴ Department of Public Health, St Vincent's Hospital, Melbourne, Victoria, Australia.

PMID: 32031315
DOI: 10.1111/ceo.13723

No abstract available

Publication types

Letter

MeSH terms

Collagen
Corneal Stroma
Corneal Topography
Cross-Linking Reagents
Humans
Keratoconus* / diagnosis
Keratoconus* / drug therapy
Photochemotherapy*
Photosensitizing Agents / therapeutic use
Riboflavin / therapeutic use
Ultraviolet Rays

Substances

Cross-Linking Reagents
Photosensitizing Agents
Collagen
Riboflavin